AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
AbCellera (Nasdaq: ABCL) has announced that it will release its third quarter 2024 financial results on Monday, November 4, 2024. The company will also hold an earnings conference call on the same day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). Investors and interested parties can access a live audio webcast of the earnings conference through a link that will be available on AbCellera's Investor Relations website. For those unable to attend the live call, a replay of the webcast will be made available through the same link following the conference call.
AbCellera (Nasdaq: ABCL) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 lunedì 4 novembre 2024. L'azienda terrà anche una telefonata per la conferenza sui risultati lo stesso giorno alle 14:00, ora del Pacifico (17:00, ora dell'Est). Gli investitori e le parti interessate possono accedere a un webcast audio in diretta della conferenza dei risultati tramite un link disponibile sul sito delle Relazioni con gli Investitori di AbCellera. Per coloro che non possono partecipare alla telefonata dal vivo, sarà disponibile una registrazione del webcast tramite lo stesso link dopo la conferenza.
AbCellera (Nasdaq: ABCL) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el lunes 4 de noviembre de 2024. La compañía también realizará una llamada de conferencia sobre los resultados el mismo día a las 2:00 p.m. hora del Pacífico (5:00 p.m. hora del Este). Los inversores y partes interesadas pueden acceder a un webcast de audio en vivo de la conferencia de resultados a través de un enlace que estará disponible en el sitio web de Relaciones con Inversores de AbCellera. Para aquellos que no puedan asistir a la llamada en vivo, se proporcionará una retransmisión del webcast a través del mismo enlace después de la llamada de conferencia.
AbCellera (Nasdaq: ABCL)는 2024년 3분기 재무 결과를 2024년 11월 4일 월요일에 발표한다고 발표했습니다. 회사는 같은 날 실적 컨퍼런스 콜을 오후 2시 태평양 표준시 (오후 5시 동부 표준시)에 진행할 예정입니다. 투자자와 이해관계자는 AbCellera의 투자자 관계 웹사이트에 제공될 링크를 통해 라이브 오디오 웹캐스트에 접근할 수 있습니다. 실시간 통화에 참석할 수 없는 사람들을 위해, 컨퍼런스 콜 이후 동일한 링크를 통해 재방송이 제공될 것입니다.
AbCellera (Nasdaq: ABCL) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le lundi 4 novembre 2024. La société tiendra également une conférence téléphonique sur les résultats le même jour à 14h00 heure du Pacifique (17h00 heure de l'Est). Les investisseurs et les parties intéressées peuvent accéder à un webcast audio en direct de la conférence sur les résultats via un lien qui sera disponible sur le site des Relations Investisseurs d'AbCellera. Pour ceux qui ne peuvent pas assister à la conférence en direct, une retransmission du webcast sera mise à disposition via le même lien après la conférence.
AbCellera (Nasdaq: ABCL) hat angekündigt, dass es am Montag, den 4. November 2024 seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 14:00 Uhr Pazifischer Zeit (17:00 Uhr Östlicher Zeit) eine Ergebnis-Konferenzschaltung abhalten. Investoren und interessierte Parteien können über einen Link, der auf der Webseite für Investor Relations von AbCellera verfügbar sein wird, auf ein Live-Audio-Webcast der Ergebnis-Konferenz zugreifen. Für diejenigen, die nicht an dem Live-Anruf teilnehmen können, wird eine Wiedergabe des Webcasts über denselben Link nach der Konferenz bereitgestellt.
- None.
- None.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240926882302/en/
Inquiries
Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
Source: AbCellera Biologics Inc.
FAQ
When will AbCellera (ABCL) report its Q3 2024 financial results?
What time is AbCellera's (ABCL) Q3 2024 earnings conference call?
How can I access AbCellera's (ABCL) Q3 2024 earnings call?
Will there be a replay available for AbCellera's (ABCL) Q3 2024 earnings call?
